Posters continue to write that SAS “can’t” IPO. Two examples may help.
Last year, KenVue (KVUE) IPO’ed. This is a collection of older brands (Listerine, Tylenol, etc.) from Johnson and Johnson that have poor revenue growth — barely above inflation. Like SAS, these brands are profitable, but face competition from cheaper alternatives. The IPO was a success, at least from J&J’s viewpoint. You can buy KVUE now, below its IPO price.
https://www.cnbc.com/2023/05/03/jj-kenvue-ipo-what-to-know.html
This week, Reddit (RDDT) will IPO. This is their second attempt; they pulled their IPO in 2021 due to poor market conditions. Reddit has revenue growth, but in its 20-year history, the company has never made a profit. If you wait a few weeks, you can probably buy RDDT also below its IPO price.
https://www.forbes.com/sites/greatspeculations/2024/03/06/reddit-return-of-the-junk-stock-ipo/
Per these examples, any company can IPO. Neither growth nor profits are required.
To IPO, the SEC does require three years of audited financial statements. Since “IPO-readiness” was announced in 2021, SAS should be “IPO-ready” early in 2025.
This doesn’t mean that SAS will IPO. “IPO-readiness” is an option, not a commitment. A private sale may be preferable. Or, like Reddit, SAS could delay an IPO if market conditions are poor.
The Majority Owner of SAS has been in business for fifty years. An experienced businessman might well solicit offers from both private buyers and a public IPO, and then take the highest bid.